Skip to main content
Clinical Trials/ISRCTN18578323
ISRCTN18578323
Completed
Not Applicable

Randomised controlled trial to assess the efficacy of a comprehensive secondary prevention programme in primary care

Sardenya Primary Care Center (in collaboration with the Catalan Foundation Institute of Pharmacology) (Spain)0 sites2,100 target enrollmentApril 4, 2005

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiovascular disease
Sponsor
Sardenya Primary Care Center (in collaboration with the Catalan Foundation Institute of Pharmacology) (Spain)
Enrollment
2100
Status
Completed
Last Updated
11 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 4, 2005
End Date
TBD
Last Updated
11 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Sardenya Primary Care Center (in collaboration with the Catalan Foundation Institute of Pharmacology) (Spain)

Eligibility Criteria

Inclusion Criteria

  • Patients are recruited from 42 primary health care centres from eight different regions of Spain (2100 patients are expected to be recruited).
  • Inclusion Criteria:
  • Males and females below 86 years, diagnosed with coronary heart disease (CHD), stroke or peripheral vascular disease in the last year.

Exclusion Criteria

  • 1\. Patients diagnosed with cardiovascular disease (CVD) before the year 2004
  • 2\. Unstable patients (post myocardial infarction \[MI] angina of less than 28 days after discharge, ventricular arrhythmias in the last six months)
  • 3\. Subarachnoid haemorrhage, cerebral embolisms secondary to valve disease
  • 4\. Patients with concomitant serious chronic disease (cancer, chronic renal failure, etc.)
  • 5\. Patients with poor mental function or any other reason to expect that the patient may have difficulty in complying with the requirements of the study

Outcomes

Primary Outcomes

Not specified

Similar Trials